StockTipsArenaBeta

BUY Divi's Laboratories Limited — Rajesh Palviya, Axis Securities

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))26 Aug 2026via ET Now

Entry₹8,744.5Inferred
Target₹9,200
Total upside +5.21% (call closed)
Stop loss₹8,550-2.22% risk
Exit₹9,20028 Aug 2026, 10:00 am
Target hit+5.21%0.00%upside left
Follow Rajesh Palviya for new calls(27% target hit, 183 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Swing call on DIVISLABSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Aug 2026
6 supporting1 opposing
Supports the BUY call (6)

PNB Housing, Divi's Labs Touch 52-Week Highs on Aug 26

NewsGoogle News·26 Aug · yesterday

(opens in new tab)

2 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·26 Aug · yesterday

Divi’s, TVS Motors, Dixon See Bullish Signals: Analyst

NewsGoogle News·26 Aug · 2d ago

(opens in new tab)

Divis Laboratories fixes July 24 record date for ₹30 dividend

NewsGoogle News·25 Aug · 3d ago

(opens in new tab)

Divi's Laboratories recommends ₹30 dividend, outlines TDS compliance

NewsGoogle News·23 Aug · 4d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Indian Pharma Stocks Face Volatility After US Tariff Proposal

NewsGoogle News·14 Aug · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Rajesh Palviya, Axis Securities

Every call and its outcome